What Users Think about the Differences between Caffeine and Illicit/Prescription Stimulants for Cognitive Enhancement

: Pharmacological cognitive enhancement (CE) is a topic of increasing public awareness. In the scientific literature on student use of CE as a study aid for academic performance enhancement, there are high prevalence rates regarding the use of caffeinated substances (coffee, caffeinated drinks, caffeine tablets) but remarkably lower prevalence rates regarding the use of illicit/prescription stimulants such as amphetamines or methylphenidate. While the literature considers the reasons and mechanisms for these different prevalence rates from a theoretical standpoint, it lacks empirical data to account for healthy students who use both, caffeine and illicit/prescription stimulants, exclusively for the purpose of CE. Therefore, we extensively interviewed a sample of 18 healthy university students reporting non-medical use of caffeine as well as illicit/prescription stimulants for the purpose of CE in a face-to-face setting about their opinions regarding differences in general and morally-relevant differences between caffeine and stimulant use for CE. 44% of all participants answered that there is a general difference between the use of caffeine and illicit/prescription stimulants for CE, 28% did not differentiate, 28% could not decide. Furthermore, 39% stated that there is a moral difference, 56% answered that there is no moral difference and one participant was not able to comment on moral aspects. Participants came to their judgements by applying three dimensions: medical, ethical and legal. Weighing the medical, ethical and legal aspects corresponded to the students' individual preferences of substances used for CE. However, their views only partly depicted evidence-based medical aspects and the ethical issues involved. This result shows the need for well-directed and differentiated information to prevent the potentially harmful use of illicit or prescription stimulants for CE.

Tags
Data and Resources
To access the resources you must log in

This item has no data

Identity

Description: The Identity category includes attributes that support the identification of the resource.

Field Value
PID https://www.doi.org/10.1371/journal.pone.0040047
PID pmc:PMC3386931
PID pmid:22768218
URL https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386931/
URL http://dx.plos.org/10.1371/journal.pone.0040047
URL https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0040047&type=printable
URL https://doaj.org/article/ba98c3e40a82418eb730694e8f88d6b0
URL https://paperity.org/p/61302020/what-users-think-about-the-differences-between-caffeine-and-illicit-prescription
URL http://europepmc.org/articles/PMC3386931
URL https://academic.microsoft.com/#/detail/2005120290
URL http://europepmc.org/articles/PMC3386931?pdf=render
URL http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0040047
URL https://doaj.org/toc/1932-6203
URL https://core.ac.uk/display/56717090
URL http://dx.doi.org/10.1371/journal.pone.0040047
URL https://dx.plos.org/10.1371/journal.pone.0040047
Access Modality

Description: The Access Modality category includes attributes that report the modality of exploitation of the resource.

Field Value
Access Right Open Access
Attribution

Description: Authorships and contributors

Field Value
Author Andreas G Franke
Author Klaus Lieb
Author Elisabeth Hildt
Contributor Taffe, Michael
Publishing

Description: Attributes about the publishing venue (e.g. journal) and deposit location (e.g. repository)

Field Value
Collected From PubMed Central; UnpayWall; Datacite; DOAJ-Articles; Crossref; Microsoft Academic Graph
Hosted By Europe PubMed Central; PLoS ONE
Journal PLoS ONE, 7, 6
Publication Date 2012-06-29
Publisher Public Library of Science
Additional Info
Field Value
Language English
Resource Type Other literature type; Article
keyword Q
keyword R
keyword keywords.General Biochemistry, Genetics and Molecular Biology
system:type publication
Management Info
Field Value
Source https://science-innovation-policy.openaire.eu/search/publication?articleId=dedup_wf_001::e2fa0c09feac89c6e662ce712ff39173
Author jsonws_user
Last Updated 22 December 2020, 21:05 (CET)
Created 22 December 2020, 21:05 (CET)